Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Performance and Safety of APP RITA in Increasing the Therapeutic Adherence of Onco-Hematological Patients - a Prospective Monocentric Pre-Market Study with a Historical Group of Comparison

NCT05260203 is registered in ClinicalTrials.gov with Advice Pharma Group srl as lead sponsor.

NCT NCT05260203
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05260203 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Performance and Safety of APP RITA in Increasing the Therapeutic Adherence of Onco-Hematological Patients - a Prospective Monocentric Pre-Market Study with a Historical Group of Comparison
Lead sponsor
Advice Pharma Group srl
Phase
Not applicable
Overall status
Completed
Start date
June 4, 2022
Completion date
January 16, 2023
Enrollment
124 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia, amyloidosis, b-cell non hodgkin lymphoma, chronic lymphocytic leukemia, chronic myeloid leukemia, chronic myeloproliferative disorder, hodgkin lymphoma, lymphocytic lymphoma, multiple myeloma, myelodysplasia, solitary plasmacytoma, t cell non-hodgkin lymphoma, treatment adherence, treatment adherence and compliance